ADIL-Phase 3 data due (approx 6 months from Feb 22 or sooner)

ADIL expects phase 3 data to arrive 6 months after the last patient was dosed in the trial. This happened on Feb 22, 2022. The date for the catalyst is an estimate, and data can come out sooner than expected. However, a big part of phase 3 studies is how much time patients were taking the drug, therefor it would be a surprise if the data came out much earlier than Aug 22.  Having said that, Top Line data that exists is apparently already sufficient to yield results, so this event could happen sooner than later.  Runup Traders will probably have the advantage here, being able to monitor the 4hr and 1hr technicals for a bullish period to start anytime in the 6 weeks before the official last day these numbers could be released is.